Direct‐acting antivirals for chronic hepatitis C
enfresMillions of people worldwide suffer from hepatitis C, which can lead to severe liver disease, liver cancer, and death. Direct‐acting antivirals (DAAs), e.g. sofosbuvir, are relatively new and expensive...enmshrfresDirect‐acting antivirals for chronic hepatitis C Background Millions of people...
Gespeichert in:
| Hauptverfasser: | , |
|---|---|
| Dokumenttyp: | Article (Journal) |
| Sprache: | Englisch |
| Veröffentlicht: |
2017/09/18
|
| In: |
The Cochrane database of systematic reviews
Year: 2017, Heft: 9 |
| ISSN: | 1469-493X |
| DOI: | 10.1002/14651858.CD012143.pub3 |
| Online-Zugang: | Verlag, Volltext: http://dx.doi.org/10.1002/14651858.CD012143.pub3 Verlag, Volltext: http://cochranelibrary-wiley.com/doi/10.1002/14651858.CD012143.pub3/full 
|
| Verfasserangaben: | Jakobsen JC, Nielsen EE, Feinberg J, Katakam KK, Fobian K, Hauser G, Poropat G, Djurisic S, Weiss KH, Bjelakovic M, Bjelakovic G, Klingenberg SL, Liu JP, Nikolova D, Koretz RL, Gluud C |
| Zusammenfassung: | enfresMillions of people worldwide suffer from hepatitis C, which can lead to severe liver disease, liver cancer, and death. Direct‐acting antivirals (DAAs), e.g. sofosbuvir, are relatively new and expensive...enmshrfresDirect‐acting antivirals for chronic hepatitis C Background Millions of people worldwide suffer from hepatitis C, which can lead to severe liver disease, liver cancer, and death. Numerous previous... |
|---|---|
| Beschreibung: | Gesehen am 09.07.2018 |
| Beschreibung: | Online Resource |
| ISSN: | 1469-493X |
| DOI: | 10.1002/14651858.CD012143.pub3 |